Background: Preventable adverse drug events (ADEs) are common in both outpatient and inpatient settings. However, the proportion of preventable ADEs varies considerably in different studies, even when conducted in the same setting, and methods for assessing the preventability of ADEs are diverse. Objective: The aim of this article is to identify and systematically evaluate methods for assessing the preventability of ADEs. Data sources: Seven databases (Cochrane, CINAHL, EMBASE, IPA, MEDLINE, PsycINFO and Web of Science) were searched in September 2010 utilizing the databases' index terms and other common terminology on preventable ADEs. No limits for the years of publication were set. Reference lists of included original articles and relevant review articles were also screened. Study selection: After applying predetermined inclusion and exclusion criteria on 4161 unique citations, 142 (3.4%) original research articles were included in the review. One additional article was included from reference lists. Outcome measures of included studies had to include the frequency of ADEs and the assessment of their preventability. Studies were excluded if they focused on individuals with one specific type of treatment, medical condition, medical procedure or ADE. Data extraction: Measurement instruments for determining the preventability of ADEs in each article were extracted and unique instruments were compared. The process of assessing the preventability of ADEs was described based on reported actions taken to standardize and conduct the assessment, and on information about the reliability and validity of the assessment. Data synthesis: Eighteen unique instruments for determining the preventability of ADEs were identified. They fell under the following four groups: (i) instruments using a definition of preventability only (n = 3); (ii) instruments with a definition of preventability and an assessment scale for determining preventability (n = 5); (iii) instruments with specific criteria for each preventability category (n = 3); and (iv) instruments with an algorithm for determining preventability (n = 7). Of actions to standardize the assessment process, performing a pilot study was reported in 21 (15%), and use of a standardized protocol was
reported in 18 (13%), of the included 143 articles. Preventability was assessed by physicians in 86 (60%) articles and by pharmacists in 41 (29%) articles. In 29 (20%) articles, persons conducting the assessment were described as trained for or experienced in preventability assessment. In 94 (66%) articles, more than one person assessed the preventability of each case. Among these 94 articles, assessment was done independently in 73 (51%) articles. Procedures for managing conflicting assessments were diverse. The reliability of the preventability assessment was tested in 39 (27%) articles, and 16 (11%) articles referred to a previous reliability assessment. Reliability ranged from poor to excellent (kappa 0.19-0.98; overall agreement 26-97%). Four (3%) articles mentioned assessing validity, but no sensitivity or specificity analyses or negative or positive predictive values were presented. Conclusions: Instruments for assessing the preventability of ADEs vary from implicit instruments to explicit algorithms. There is limited evidence for the validity of the identified instruments, and instrument reliability varied significantly. The process of assessing the preventability of ADEs is also commonly imprecisely described, which hinders the interpretation and comparison of studies. For measuring the preventability of ADEs more accurately and precisely in future, we believe that existing instruments should be further studied and developed, or that one or more new instruments should be developed, and the validity and reliability of the existing and new instruments be established.
Background
Adverse events (AEs) resulting from medication therapy are common causes of morbidity and mortality in healthcare. [1, 2] These events are referred to as adverse drug events (ADEs) in this review. According to one definition, ADEs that result from a medication error, a failure in the medication use process, such as prescribing, dispensing or administration of medicines, are considered to have been preventable. [3] Preventable ADEs occur in both outpatient and inpatient settings. [4] [5] [6] [7] The estimated frequencies of preventable ADEs and the supposed preventability rates of ADEs vary considerably in different studies. A systematic review of preventable ADEs in ambulatory care found that per 1000 patient-months the median incidence of ADEs was 14.9 and the median ADE preventability rate was 21% (range 11-38%). [5] Another systematic review concluded that the median percentage of preventable drug-related hospital admissions was 3.7% (range 1.4-15.4%). [4] In a review of ADEs in hospitalized patients, the preventability rate ranged from 15-90%. [6] Also, an older review reported that the preventability rate of ADEs in hospital settings ranged from 19-73%, with a median of 35%; the median frequency of preventable ADEs was 1.8% (range 1.3-7.8%). [7] In systematic reviews, the heterogeneity between studies assessing preventable ADEs has been described as a barrier for conducting a meta-analysis on preventable ADEs. [4, 5] Using different definitions for adverse outcomes and preventability has been suggested to decrease the comparability of different studies. [6, 7] While some research groups have repeatedly assessed the preventability of ADEs reliably, [8, 9] some have found only fair agreement on the assessment of preventable ADEs and have criticized the lack of reliable methods for assessing preventable ADEs. [10] A recent narrative systematic review, outlining and discussing how preventable adverse drug reactions (ADRs) and preventability of ADRs are defined, found that several definitions are used and that existing approaches are limited. [11] Thus, a better understanding of the methods used to assess the preventability of ADEs is required. We are unaware of a systematic review that has explicitly focused on evaluating methods for assessing the preventability of ADEs in both the outpatient and inpatient settings, and that has systematically compared the applied methods against the same pre-defined criteria. Therefore, this review was undertaken to identify and systematically evaluate different methods for assessing the preventability of ADEs, excluding methods investigating potential ADEs and the potential preventability of ADEs.
Literature Review Methods

Terminology
An ADE is defined as 'an injury resulting from medical intervention related to a drug'. [8] In this review, ADEs include ADRs and other adverse health outcomes associated with medication therapy, such as ADEs due to drug intoxication, drug dependence, under-treatment and therapeutic failure. When we refer to ADEs in this review, the relationship between a negative health outcome and medication therapy has been assessed. Studies of medication errors, drug-related problems (DRPs) and potentially inappropriate medicines were considered in this review, only if actual adverse health outcomes were investigated. Without assessment of 'injury resulting from medical intervention related to a drug', studies on, for example, potentially inappropriate medicines according to the Beers criteria [12] would not meet the definition of an ADE in our study.
As there is no universally accepted definition for the preventability of ADEs, we considered all studies investigating the preventability of ADEs, regardless of how this was defined. With preventability assessment of ADEs, we refer to a case-by-case assessment. Studies in which potential preventability of ADEs was investigated were not considered. We did not include studies that first addressed the occurrence of medication errors, and then addressed whether or not the errors caused harm, and which concluded that errors with harm were preventable ADEs. The preventability of ADEs is not assessed in such studies.
Data Sources
Seven databases, the Cochrane database of systematic reviews, Cumulative Index to Nursing & Allied Health Literature (CINAHL), Excerpta Medica Database (EMBASE), International Pharmaceutical Abstract (IPA), MEDLINE, PsycINFO and Web of Science were searched (up to September 2010) by one researcher (KMH). Database index terms and other commonly used terminology about ADEs and preventability were used (Appendix 1). The search was limited to publications in English. No lower limit was set for the year of publication. References of included original articles and relevant review studies identified in the database search or through other sources were also retrieved. Citations unavailable through the databases, library or internet were retrieved by contacting corresponding authors or research institutes.
Study Selection
Original peer-reviewed research articles were included in the review according to predetermined inclusion and exclusion criteria. Commentaries, editorials, letters, guidelines, reports, conference proceedings, case reports, conceptual papers and other non-original research articles were excluded. Studies of chemical compounds other than medicines, and studies of pharmacodynamic, pharmacokinetic and pharmacogenetic measures, were also excluded. Outcome measures of included studies had to include the frequency of ADEs or synonymous concepts and an assessment of ADE preventability. Thus, studies of errors or potential AEs, without information about actual AEs, were excluded. The required outcome measures had to be reported in the results sections of the studies. Articles summarizing previous results, without original assessment of the preventability of ADEs, were excluded. Studies were also excluded if they focused on specific treatments or other health interventions (e.g. patients taking antidepressants), diagnostic procedures (e.g. patients having colonoscopy), types of ADE (e.g. renal failure), disease areas or medical conditions (e.g. patients with depression), and if the settings or sampling frame of the study represented one or two specific disease areas (e.g. cardiac intensive care unit). Original studies published in languages other than English were excluded.
A total of 5770 citations were found in the database search (figure 1). After removal of duplicate records, the abovementioned inclusion and exclusion criteria were applied to titles of 4161 unique citations. Subsequently, 1751 abstracts were reviewed against the same criteria. Based on the abstract review, the inclusion and exclusion criteria were applied to the full text of 386 articles. Of the 4161 unique citations, 142 articles (3.4%) fulfilled the inclusion criteria. As one additional article was included from reference lists, a total of 143 articles were included in the review. Screening and selection of articles was done by one researcher (KMH). Two articles that fulfilled the inclusion criteria, based on the abstract, could not be retrieved through several libraries internationally, or through contacting the authors and research institutes, and were therefore excluded from the review. [13, 14] 
Data Extraction
Data extraction from the included articles was performed using a pilot tested data collection template. Extracted characteristics of the articles included information about study design, data source, setting, sampling frame, characteristics of the study population and outcome measures. The measurement instruments used for defining the preventability of ADEs in the included articles were identified and, when referenced, original publications about the measurement instruments were retrieved. These publications could include scientific articles and 'grey literature', such as professional publications, in any language. Unique measurement instruments used in at least one included article, besides the original publication, were classified and compared. A measurement instrument was considered unique when it was not introduced in previous articles and when it had a new way of categorizing or defining preventability. When evaluating the uniqueness of an instrument, the functional meaning of wording was evaluated and small changes in wording were overlooked. When an introduced instrument did not appear unique but was reported as unique and was not referenced, the introduced instrument was analysed as unique.
The process of assessing the preventability of ADEs in each article was assessed based on reported actions that may influence the validity and reliability of the measurement. [15] [16] [17] First, information about standardizing the assessment process through performing a pilot or using an operational manual was extracted. Second, data about persons conducting the assessment were extracted, including the assessors' profession, and training for, or experience in, preventability assessment; the number of assessors per case, and whether assessments from multiple assessors were independent of each other; and procedures for managing conflicting assessments. Third, the reported reliability and validity of the preventability assessment was extracted from each article. The extracted data were based on data reported in the included articles. Authors were not contacted when information was missing. One researcher (KMH) conducted the data extraction.
Results
The characteristics of the 143 included studies are presented in table S1 (Supplemental Digital Content, http://links.adisonline.com/drugsafety/ A59). Thirty-eight (27%) articles investigated the preventability of ADRs, excluding other types of ADEs. The preventability of ADEs was studied in 65 (45%) articles. [8, 9, Fifteen (10%) articles examined the preventability of all medical AEs, not only drug-related outcomes. [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] The remaining 25 (17%) articles studied the preventability of otherwise defined drug-related morbidity, such as drugrelated hospital admissions.
Among the 143 included studies, 18 unique instruments for determining the preventability of ADEs were identified (table I, figure 2 ). The instruments fell under four groups, with different degrees of structure. The preventability instruments in the first group are the most implicit and in the fourth group the most explicit.
The first group, consisting of instruments using only a definition of preventability, included three instruments [8, 56, 159] (table I, figure 2 ). All three instruments shared the same preventability categories, and no specific criteria for determining the type of preventability category, apart from the definition for preventability, were mentioned. The oldest instrument by Dubois and Brook [159] was originally developed for analysing the preventability of deaths. The two other instruments, developed to assess specifically the preventability of ADEs, originated from Dubois' instrument.
In the second group, consisting of instruments with a definition of preventability and a scale for determining preventability category, five unique instruments were identified [57, 119, [160] [161] [162] (table I, figure 2 ). In these instruments, the preventability of AEs was determined using a confidence scale from 0 to 6 [119, [160] [161] [162] or a 5-point Likert scale. [57] Apart from the instrument from Kaushal et al., [57] these instruments were developed to assess the preventability of AEs, not only ADEs, and they derived from the first instrument by Hiatt and colleagues. [160] The third group included three instruments with specific criteria for each preventability category [58, 134, 163] (table I, figure 2). Two instruments had more than one category for preventable events and each category had its own criteria. [58, 134] In one instrument, preventability was categorized dichotomously and preventable events had to fulfill three criteria. [163] All three instruments in this group were developed for drug-related AEs. The instruments were not derived from each other. However, a 6-point confidence scale in the instrument by Gandhi and colleagues [58] originated from the confidence scale first published by Hiatt and colleagues. [160] [163] NS DRM 3 criteria that all must be fulfilled to grant preventability [58] Ambulatory In the instrument from Hallas and colleagues, [134] a case was definitely avoidable when 'the drug event was due to a drug treatment procedure inconsistent with present-day knowledge of good medical practice or was clearly unrealistic, taking the known circumstances into account', possibly avoidable when 'the prescription was not erroneous, but the drug event could have been avoided by an effort exceeding the obligatory demands', and not avoidable when 'the drug event could not have been avoided by any reasonable means, or it was an unpredictable event in the course of a [162] Dubois and Brook (1988), [159] Gandhi et al. (2003), [58] Hallas et al. (1990) , [134] Hepler and Strand (1990), [163] Hiatt et al. (1989) , [160] Imbs et al. (1998), [165] Kaushal et al. (2001), [57] Lau et al. (2003), [168] Livio (1998), [166] Olivier et al. (2005), [169] Schumock and Thornton (1992), [164] Thomas et al. (2000), [119] Wilson et al. (1995) [161] and Winterstein et al. (2002) . [59] treatment fully in accordance with good medical practice'. Unlike any other identified instrument, the instrument from Hallas and colleagues [134] included a category of unevaluable for cases in which data for rating were not available or evidence was conflicting. According to Hepler and Strand, [163] a case was preventable when the undesirable clinical outcome was foreseeable, and the cause of the outcome was identifiable and controllable. Among included unique instruments, the instrument from Gandhi and colleagues [58] was the only one considering ameliorable ADEs as a preventability category.
Seven instruments fell under the fourth group, consisting of instruments with an algorithm for determining preventability [59, [164] [165] [166] [167] [168] [169] (table I, figure 2 ). All seven instruments were developed for drug-related AEs. The instruments by Winterstein and colleagues, [59] Baena and colleagues, [167] and Lau and colleagues [168] were modified from the one by Schumock and Thornton, [164] while the instrument by Livio and colleagues [166] appeared to originate from that by Schumock and Thornton [164] The instrument by Olivier and colleagues [169] derived from the one by Imbs and colleagues. [165] In all seven instruments, preventability was assessed using an explicit algorithm consisting of statements indicating that an error was present. A case was categorized in an appropriate preventability category based on the number of valid statements. In the instrument by Schumock and Thornton, [164] for example, preventability was categorized dichotomously (preventable/not preventable) based on seven statements concerning possible contraindications, inappropriate dose, inappropriate therapeutic drug monitoring, not considering previous allergic reactions to the drug, drug interactions, toxic serum drug concentrations and compliance. If at least one statement was valid, the case was judged preventable.
Actions taken to standardize the process of assessing preventability were rarely described (table II) . Performing a pilot study, where the preventability assessment is evaluated and the method adjusted according to feedback, was reported in 21 (15%) articles. Eighteen (13%) articles described the use of an operation manual, guidelines or other standardized protocol for the assessment of preventability.
In 86 (60%) articles, the preventability assessments were made by physicians, and in 41 (29%) articles by pharmacists, often a combination of both. In 50 (35%) articles, the profession of the assessors was unclear or not reported. In 29 (20%) articles, the assessors were described as trained for, or experienced in, such preventability assessment. Among the 94 (66%) articles with more than one person assessing the preventability of each case, an independent assessment was reported in 73 (51%) articles. Procedures for managing conflicting assessments were diverse.
The reliability of the preventability assessment was reported in 39 (27%) articles, and 16 (11%) articles referred to a previous reliability assessment (table II) . The results of the reliability assessments reported in the included articles are summarized in table III. Although no definite guidelines for determining sufficient reliability exist, reliability is commonly considered good when the kappa value is 0.61-0.80, and very good when the kappa value is 0.81-1.00. [174] Lower kappa indicates moderate (0.41-0.60), fair (0.21-0.40) or poor (<0.20) reliability. Thus, interrater reliabilities ranged from poor to excellent (kappa 0.19-0.98; overall agreement 26-97%). Of the 24 (17%) articles that reported excellent reliability of the preventability assessment (kappa >0.81), one study used an explicit algorithm in the fourth group, [60] and 23 studies used more implicit methods. [8, 9, [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [119] [120] [121] In four (3%) articles, reliability assessments were mentioned, but as no exact figures for reliability of the preventability assessment were presented, the articles are not presented in table III. [18, 57, 79] In addition, two (1%) articles reported reliability of the preventability assessment in a non-comparable manner and are thus not presented in table III. [135, 136] Four (3%) articles mentioned assessing validity of the preventability assessment. [19, 78, 80, 122] In one (1%) article, [19] an assessment method introduced by the authors was compared with a previously introduced method and the number of identified cases by the two methods was reported. However, no sensitivity or specificity analysis or negative or positive predictive values were reported. Three articles (2%) mentioned previous a Some articles using multiple strategies fell under several categories. NR = not reported. [121] Inter-rater reliability between two reviewers 0.84 [78] Inter-rater reliability between two reviewers 0.95 [76] Buckley et al. (2007) [120] Inter-rater reliability and agreement between two reviewers [75] Inter-rater reliability between two reviewers 0.67 [127] Inter-rater reliability and agreement between two reviewers 0.31 (95% CI 0.05, 0.57) 67.8% [128] Inter-rater reliability and agreement between two reviewers 0.44 83% [77] Inter-rater reliability between two reviewers 0.89 (95% CI 0.84, 0.95) [74] Inter-rater reliability and agreement between two reviewers [102] Inter-rater reliability between two reviewers 0.59 [103] Inter-rater reliability between two reviewers 0.80 (95% CI 0.67, 0.82)
Zandieh et al. (2008)
Kaushal et al. (2007)
Sari et al. (2007)
Wang et al. (2007)
Kopp et al. (2006)
Walsh et al. (2006)
Al-Tajir and Kelly (2005) [104] Inter-rater reliability and agreement between two reviewers 0.74 86.9% [105] Inter-rater reliability and agreement between two reviewers 0.60 82% [106] Inter-rater reliability between two reviewers 0.49 [108] Inter-rater reliability between two reviewers 0.70 [109] Inter-rater reliability and agreement between two reviewers [123] Inter-rater reliability and agreement between two reviewers Preventability: 0. [58] Inter-rater reliability between two reviewers 0.70 (95% CI 0.62, 0.78)
Forster et al. (2005)
Gurwitz et al. (2005)
Weingart et al. (2005)
Hardmeier et al. (2004)
Howard (2003) [148] Inter-rater reliability between three reviewers [19] Inter-rater reliability between four reviewers 0.14-0.58 [116] Inter-rater reliability between two reviewers 0.73
Gurwitz et al. (2000)
Thomas et al. (2000) [119]
Inter-rater reliability and agreement between original reviewers' and investigators
91%
Gray et al. (1998) [60] Inter-rater reliability between two reviewers 0.84 , [8] referenced by [61] [62] [63] [64] [65] [66] [67] [68] [69] Inter-rater reliability and agreement between two reviewers 0.92 96%
Cullen et al. (1995) [9] Inter-rater reliability between two reviewers 0.98 Bates et al. (1993) , [56] referenced by [85, 118] Inter-rater reliability between two reviewers 0.71 Kramer et al. (1985) [54] Inter-rater reliability between two reviewers Weighted kappa +0.379
Reliability assessment reported in another cited article Zegers et al. (2010), [170] referenced by [137] Inter-rater reliability within and between pairs of reviewers [171] referenced by [85, 91] Inter-and intra-rater reliability between three reviewers
Overall inter-rater reliability 0. [172] referenced by [127] Inter-rater reliability and agreement between three reviewers 0.31 (CI 0.05, 0.57) 67.8% Thomas et al. (2002) , [173] referenced by [131] Inter-rater reliability between three assessment methods 0.19-0.24 (lowest bound of 95% CI 0.05 and highest 0.37)
referenced by [122] Inter-rater reliability between two reviewers 0.60 a References that report the reliability of the same study are in the same column. validity assessments, [78, 80, 122] but no results of the validity assessments were presented.
Discussion
We identified 18 unique instruments for assessing the preventability of ADEs, varying from implicit instruments defining preventability loosely, to explicit algorithms in which criteria for preventability were clearly expressed. In the most implicit instruments, the reviewers of a case used only the definition of preventability to determine whether an ADE was preventable. In explicit algorithms, the reviewers assessed preventability by applying an explicit list of statements. While the levels of structure and wording in defining preventability were diverse, all instruments shared the same basis for defining preventability: whether an error or sub-standard care had resulted in an ADE.
There is conflicting evidence on which instruments have the highest reliability for assessing the preventability of ADEs. We found that reliability was not reported in most articles and, when reported, it varied markedly across studies. A previous study demonstrated that intra-and inter-rater reliabilities of preventability judgements of ADEs were poorer when using implicit instruments rather than an explicit algorithm, [175] perhaps due to the larger impact of an individual reviewer's clinical judgement in implicit instruments. The poor reliability of assessing the preventability of deaths using implicit methods has also been criticized, [176] and the need for the development of more explicit methods for assessing the preventability of AEs and the appropriateness of care has been recognized by several authors. [176, 177] However, we did not find evidence of better reliability when explicit algorithms were used. In contrast, implicit methods appeared to result in excellent reliability more commonly (although this review does not allow pooling reliabilities). A study of medicationrelated events among paediatric inpatients also found that the inter-rater reliability of assessing preventability was poor when a highly structured algorithm was used. [171] The lack of practice standards and the common, often justified, use of unlicensed medicines in paediatrics may cause difficulty in interpreting a highly structured algorithm and may lead to misclassification of preventable cases and poor reliability. It has also been argued that when the aim of a study is to assess all AEs, not only drug-specific ones, creating explicit criteria for preventability is impossible and therefore implicit judgement is required. [123] External and internal reliability may also differ for identified instruments. The internal reliability, i.e. the same assessors coming to the same conclusion when cases are re-assessed, may be excellent when the assessors in well established research groups are competent and experienced. If other assessors assessing the same cases using the same instrument do not come to the same conclusion, the assessment lacks external reliability. Zegers and colleagues, [170] using implicit methods, found that inter-rater reliability within pairs of assessors was higher than between assessors, indicating poor external reliability. As assessors' clinical judgement is crucial when using implicit instruments, such instruments may be sensitive to variations in external reliability, even though they have good internal reliability. Considering the scattered evidence about the external and internal reliability of measuring the preventability of ADEs, the reliability of the preventability assessment should be described in published articles. Comparing the reliability of different measurement instruments, for example, algorithms and implicit judgements, [175] in different settings and in a single dataset would also provide important evidence about the potential to improve reliability. As reliability is an important indicator of the potential for a measurement to be valid, [17] reliability should be assessed in conjunction with validity testing.
The validity of the preventability assessment was rarely mentioned in the included articles and there is little evidence about the validity of the methods. As there is no gold standard for assessing ADEs or AEs, [20, 173] some researchers argue that validity cannot be studied. [173] A gold standard is required for assessing criterion validity when a new instrument is developed to improve the feasibility of the measurement compared with a previous instrument. [17] However, without a gold standard, other types of validity could be explored. Convergent and discriminant validity, for example, could be assessed by comparing the measurement using an instrument with variables known to correlate or not correlate with the new measurement.. For instance, preventability should correlate with whether a patient has been compensated due to an error in the care process. An instrument would indicate validity if the variables were found to be somewhat correlated. Recently, a descriptive scheme for assessing the theoretical preventability of ADRs was introduced by Aronson and Ferner. [178] The scheme's explicit flowchart for determining preventability, based on previously introduced classification systems of ADRs, could be assessed for representation validity using, for example, an expert group, i.e. to investigate how well operational definitions translate into measurable outcomes. Even though investigating the validity of preventability assessments is challenging, it is essential for measuring the preventability of ADEs more accurately, scientifically and rigorously in future.
In the identified measurement instruments, the preventability categories varied from dichotomous (yes/no) to 4-point ordinal categories. In dichotomous categorization, in general, the continuous nature of the studied phenomenon is disregarded and there is a risk of error if reviewers have different perceptions of the boundary of a positive and negative response. [179] In addition, fewer categories than reviewers' capability to discriminate may result in loss of information, which may lead to reduced reliability. Thus, allowing reviewers' insecurity about their preventability assessment, through inclusion of categories such as possibly preventable, is likely to be advantageous. A confidence scale used in the second group of instruments, where only cases with certain confidence are categorized as preventable, has also been reported to increase the reliability of assessment. [180] Optimal categorization should be studied in future, as there is little evidence about which preventability categories produce the most reliable and valid results.
Descriptors such as definite, probable and possible were used to label different categories of preventability in the assessed instruments. In the literature about health outcome measurement, the use of imprecise, verbal terms for probability is discouraged because different reviewers may interpret such terms differently. [179] In one study, the inter-reviewer agreement between clinicians was poor when clinicians assigned values to verbally described probabilities; for example, estimates for highly probable ranged from 60-99%. [181] The challenge of interpreting verbally described probabilities may, however, be less problematic when using instruments in the second group, where preventability was determined according to an estimated, numerical level of evidence or confidence that the event was preventable. As the reliability of preventability assessments of ADEs with current methods varies, investigating the use of more precise, numerical categories for preventability is justified.
Besides the diversity of instruments used for assessing the preventability of ADEs, the imprecisely described process of assessing preventability hinders the interpretation and comparison of studies. Assessing the preventability of ADEs is considered challenging, and standardizing the assessment process improves the reliability of a measurement. [15] However, only a few articles reported pilot studies or the use of operational manuals. This may be due to space constraints in publications, or because the assessment process was the same in previous studies in similar settings, in which case a new pilot is not always necessary. Assessors' professions and training for, or experience in, assessing preventability were diverse and also commonly not reported; the same was true for the number of assessors and for procedures for managing conflicting assessments. Even though there is little evidence about who and how the preventability of ADEs can be assessed in the most valid and reliable manner, the profession and competence of assessors, [15, 182, 183] the number of assessors, [173] and procedures for managing conflicting assessments [184, 185] may influence reliability and validity of the measurement. Thus, in accordance with recently published guidelines, [186, 187] we recom-mend that authors of future studies describe the following: the reliability and validity of the preventability measurement; the actions taken to standardize the measurement; assessors' professions and training for, or experience in, assessing preventability; the number of assessors; whether assessors assessed each case independently; and how conflicting assessments were managed. The varying pharmacological nature of different types of ADEs, such as ADRs, drug intoxications from overdose and therapeutic failures, has to be considered when assessing ADE preventability. Some ADEs can be prevented pharmacologically, for example, by increasing the dose slowly when there is a risk for an early ADR associated with tolerance. [178] Also, therapeutic failure due to under-treatment may be prevented, when the response is observable, by increasing the dose against the response. Other ADEs, such as drug intoxications from overdose, may not be prevented pharmacologically. Instead, other measures, such as patient education, may prevent these ADEs. Thus, some pharmacologically non-preventable ADEs may be preventable in practice, and some pharmacologically predictable ADEs may not be preventable in practice settings. To clarify what is meant by the preventability of ADEs in future research, different scenarios for the preventability of different types of ADEs should be described. Based on the scenarios, a clear, shared definition for preventability (and its relationship to medication errors, and predictability) should be established, as multiple definitions are currently used. [188] Due to the limitations and diversity of instruments used, it is unknown whether variation in preventability rates in different settings and populations depends on methodology or actual differences in the preventability of ADEs. Assessing preventability rates accurately requires more evidence about the methodology of measurement. Although modifying previous measurement instruments or developing new ones is challenging and time-consuming, [179] we believe that existing instruments should be further investigated by several research groups working collaboratively. Based on thorough investigation, either one or more existing instruments should be further developed, or one or more new instruments for assessing the preventability of ADEs in different settings should be developed. A starting point for developing a new instrument could be creation of a clear definition for the preventability of different types of ADEs. The possibility of assessing all ADEs using a single instrument should be investigated, as the diversity of possible scenarios may hinder assessing all ADEs together. Suitable preventability categories, potentially numerical ones to improve reliability, and different structures for facilitating assessors' decision making could then be investigated in different settings. In addition, the feasibility of the assessment in research settings has to be considered. Any new instruments should also be compared with existing ones. Importantly, one or more measurement instruments should gain rigorous evidence and become a gold standard, thus enabling comparability of different studies.
Improving methods for assessing the preventability of ADEs is also in the interests of decision makers in healthcare. Patient and medication safety are on the agendas of the WHO, [189] the Council of Europe, [190] the European Medicines Agency, [191] and national health authorities. As identified by the WHO, [192] research in patient safety includes measuring harm, understanding causes, identifying solutions, evaluating impact and translating evidence into safer care. In medication safety research, assessing the preventability of ADEs is required in all these stages; for example, for evaluating interventions to decrease ADEs and preventable ADEs. Evidence from such research can be used by decision makers to improve patient safety practices.
The inconsistent terminology used to study ADEs was a limitation for investigating methods assessing preventability in this review. We used the term ADE to include not only ADRs, but also other AEs related to medication therapy. ADEs have been described to consist of medication errors, which are by definition preventable, and ADRs, which are not preventable. [3] According to this definition, assessing the preventability of ADRs would not be necessary, as ADRs are never preventable. However, as other researchers have defined ADRs differently, [193] elaborated about ADR preventability, [11] and found some element of ADR preventability, [194] studies investigating the preventability of ADRs were considered in this review.
This review included articles published in English in scientific journals. Thus, some relevant original studies may have been overlooked because we excluded unpublished studies or studies published in languages other than English. However, we believe that the most widely used and accepted methods have been published in scientific journals in English. Furthermore, no language limitations were set when evaluating unique measurement instruments in the included studies. The use of seven databases and a wide range of search terms increased the likelihood of capturing relevant articles, but as study selection was done by one researcher and the reliability of selection was not assessed, some relevant articles may not have been selected. A major limitation of this study is that only reported information in each article was extracted and authors were not contacted for complementary information. Some of the evaluated aspects of preventability assessment, such as performing a pilot study, or the use of an operational manual, may have been performed but not described in the published articles. Thus, our findings may not reflect how the preventability assessment was actually conducted. Furthermore, methods for assessing the preventability of ADEs were not assessed separately for different settings and study designs, a factor that must be considered when the results are interpreted. As data extraction and analysis were also conducted by one researcher, the results represent this researcher's interpretation of the included articles. However, we believe that the systematic data extraction procedure improved objectivity of the review.
Conclusions
Instruments for assessing the preventability of ADEs vary from implicit instruments to explicit algorithms. The level of structure differs in the identified instruments, which, nonetheless, share the same basis for defining preventability: whether an error or sub-standard care resulted in an ADE. However, there is scattered evidence for the instruments, as reliability of the preventability assessments varies markedly, validity is rarely assessed and categorization of preventability appears suboptimal. In addition, the process of assessing the preventability of ADEs is commonly imprecisely described, which hinders the interpretation and comparison of studies. For measuring the preventability of ADEs more accurately and precisely in future, we believe that existing instruments should be further studied and developed, or that one or more new instruments should be developed and have their validity and reliability established. 
